Literature DB >> 22460077

Posttranslational modification of indoleamine 2,3-dioxygenase.

Hidetsugu Fujigaki1, Mitsuru Seishima, Kuniaki Saito.   

Abstract

Protein posttranslational modifications (PTMs) perform essential roles in the biological regulation of a cell. PTMs are extremely important because they can change a protein's physical or chemical properties, conformation, activity, cellular location, or stability. In fact, most proteins are altered by the addition or removal of a chemical moiety on either an amino acid or the protein's N- or C-terminus. Some PTMs can be added and removed dynamically as a mechanism for reversibly controlling protein function. Thus, identifying the PTM sites is critical to fully understand the biological roles of any given protein. Mass spectrometry (MS) is a widely used analytical strategy to identify PTMs. We have used an automated two-dimensional liquid chromatography (LC) system coupled with electrospray ionization quadrupole ion-trap MS to identify PTMs for indoleamine 2,3-dioxygenase 1 (IDO1), one of the tryptophan catabolic enzymes. IDO1 promotes immune tolerance by suppressing local T-cell responses under various physiological and pathophysiological conditions, such as pregnancy in mammals, tumor resistance, autoimmunity, and chronic inflammation. Although many studies have demonstrated the biological importance of IDO activity, the PTMs of IDO enzymes remain largely unknown. Only a few important PTMs of IDO1 have been found, such as nitration, N-terminal acetylation, and phosphorylation. In this review, we analyze the PTMs of IDO1 using our two-dimensional LC-MS/MS system, and provide an overview of our current understanding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460077     DOI: 10.1007/s00216-012-5946-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  10 in total

Review 1.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 2.  The role of indoleamine 2,3-dioxygenase in allergic disorders.

Authors:  Seyed-Alireza Esmaeili; Jafar Hajavi
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

3.  Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications.

Authors:  Lucía Álvarez; Ariel Lewis-Ballester; Adrián Roitberg; Darío A Estrin; Syun-Ru Yeh; Marcelo A Marti; Luciana Capece
Journal:  Biochemistry       Date:  2016-05-06       Impact factor: 3.162

4.  Quantification of IDO1 enzyme activity in normal and malignant tissues.

Authors:  Lijie Zhai; Erik Ladomersky; April Bell; Corey Dussold; Krislyn Cardoza; Jun Qian; Kristen L Lauing; Derek A Wainwright
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

Review 5.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

Review 6.  Kynurenines in CNS disease: regulation by inflammatory cytokines.

Authors:  Brian M Campbell; Erik Charych; Anna W Lee; Thomas Möller
Journal:  Front Neurosci       Date:  2014-02-06       Impact factor: 4.677

7.  IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.

Authors:  Alexander Lee; Navya Kanuri; Yuanhao Zhang; Gregory S Sayuk; Ellen Li; Matthew A Ciorba
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 8.  Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Duc Hoang Le; Le Van Son; Ha Hoang Chu; Tadamitsu Kishimoto
Journal:  Front Immunol       Date:  2014-10-29       Impact factor: 7.561

9.  USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Authors:  Dongni Shi; Xianqiu Wu; Yunting Jian; Junye Wang; Chengmei Huang; Shuang Mo; Yue Li; Fengtian Li; Chao Zhang; Dongsheng Zhang; Huizhong Zhang; Huilin Huang; Xin Chen; Y Alan Wang; Chuyong Lin; Guozhen Liu; Libing Song; Wenting Liao
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694

10.  Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia.

Authors:  Pablo Zardoya-Laguardia; Astrid Blaschitz; Birgit Hirschmugl; Ingrid Lang; Sereina A Herzog; Liudmila Nikitina; Martin Gauster; Martin Häusler; Mila Cervar-Zivkovic; Eva Karpf; Ghassan J Maghzal; Chris P Stanley; Roland Stocker; Christian Wadsack; Saša Frank; Peter Sedlmayr
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.